[
  {
    "ts": null,
    "headline": "Nelson Peltz’s Trian Pushes Solventum to Further Simplify Business",
    "summary": "Activist investor Trian Fund Management is pushing  Solventum  to separate more of its businesses after the company’s $4.1 billion deal to sell its filtration unit, according to people familiar with the matter.  Nelson Peltz’s  firm has held a roughly 5% stake in Solventum since the middle of last year.  Trian believes the company should separate its dental products and software businesses and focus more on its medical and surgical unit, the people said.",
    "url": "https://finnhub.io/api/news?id=0653769b42328b8f505481c3c607143e9a5ecc912bce146f4d6b0263768eaab9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740612420,
      "headline": "Nelson Peltz’s Trian Pushes Solventum to Further Simplify Business",
      "id": 133184871,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Activist investor Trian Fund Management is pushing  Solventum  to separate more of its businesses after the company’s $4.1 billion deal to sell its filtration unit, according to people familiar with the matter.  Nelson Peltz’s  firm has held a roughly 5% stake in Solventum since the middle of last year.  Trian believes the company should separate its dental products and software businesses and focus more on its medical and surgical unit, the people said.",
      "url": "https://finnhub.io/api/news?id=0653769b42328b8f505481c3c607143e9a5ecc912bce146f4d6b0263768eaab9"
    }
  },
  {
    "ts": null,
    "headline": "Trian Comments on Solventum’s Sale of its Purification & Filtration Business",
    "summary": "NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Trian Fund Management, L.P. (“Trian”), which beneficially owns ~5% of Solventum Corporation (NYSE: SOLV) (“Solventum” or the “Company”) and is the Company’s largest active shareholder, commented on Solventum’s recently announced sale of its Purification & Filtration business to Thermo Fisher Scientific Inc (NYSE: TMO) (“Thermo Fisher”). Trian issued the following statement: “Trian commends Solventum on the announced sale of its Purification & Filtratio",
    "url": "https://finnhub.io/api/news?id=174aaf132fd88f99d2dff4e49c4be20eab66665abd96a2e21c7c9edc92ccde73",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740599400,
      "headline": "Trian Comments on Solventum’s Sale of its Purification & Filtration Business",
      "id": 133184872,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Trian Fund Management, L.P. (“Trian”), which beneficially owns ~5% of Solventum Corporation (NYSE: SOLV) (“Solventum” or the “Company”) and is the Company’s largest active shareholder, commented on Solventum’s recently announced sale of its Purification & Filtration business to Thermo Fisher Scientific Inc (NYSE: TMO) (“Thermo Fisher”). Trian issued the following statement: “Trian commends Solventum on the announced sale of its Purification & Filtratio",
      "url": "https://finnhub.io/api/news?id=174aaf132fd88f99d2dff4e49c4be20eab66665abd96a2e21c7c9edc92ccde73"
    }
  },
  {
    "ts": null,
    "headline": "Thermo Fisher Scientific Inc. stock falls Wednesday, underperforms market",
    "summary": "Thermo Fisher Scientific Inc. stock falls Wednesday, underperforms market",
    "url": "https://finnhub.io/api/news?id=ae366c9216dfb3a0ed43a425e048a5fc09ccdea12e36688b3e589b54ab3b859d",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740587640,
      "headline": "Thermo Fisher Scientific Inc. stock falls Wednesday, underperforms market",
      "id": 132882830,
      "image": "",
      "related": "TMO",
      "source": "MarketWatch",
      "summary": "Thermo Fisher Scientific Inc. stock falls Wednesday, underperforms market",
      "url": "https://finnhub.io/api/news?id=ae366c9216dfb3a0ed43a425e048a5fc09ccdea12e36688b3e589b54ab3b859d"
    }
  },
  {
    "ts": null,
    "headline": "Voya Balanced Large Cap Core-Value SMA (Merrill Lynch) Q4 2024 Commentary",
    "summary": "For the quarter ended December 31, 2024, the SMA outperformed the Index on a gross-of-fees basis due to favorable stock selection. Read more here.",
    "url": "https://finnhub.io/api/news?id=bd52b65e7c1d97899ef276469845db432c433ade296b802c93a30b8f22b1d802",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740573240,
      "headline": "Voya Balanced Large Cap Core-Value SMA (Merrill Lynch) Q4 2024 Commentary",
      "id": 132879317,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/174803644/image_174803644.jpg?io=getty-c-w1536",
      "related": "TMO",
      "source": "SeekingAlpha",
      "summary": "For the quarter ended December 31, 2024, the SMA outperformed the Index on a gross-of-fees basis due to favorable stock selection. Read more here.",
      "url": "https://finnhub.io/api/news?id=bd52b65e7c1d97899ef276469845db432c433ade296b802c93a30b8f22b1d802"
    }
  },
  {
    "ts": null,
    "headline": "Thermo Fisher strikes $4.1bn deal for Solventum’s purification and filtration unit",
    "summary": "GlobalData analyst Dr Andrew S Thompson expects the deal to prompt a \"shuffle\" in Thermo Fisher’s life sciences unit.",
    "url": "https://finnhub.io/api/news?id=aedfbae446e321f3688dd82d97faa05c27cb865785e04975ba20f1a43b8825fb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740573194,
      "headline": "Thermo Fisher strikes $4.1bn deal for Solventum’s purification and filtration unit",
      "id": 133184873,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "GlobalData analyst Dr Andrew S Thompson expects the deal to prompt a \"shuffle\" in Thermo Fisher’s life sciences unit.",
      "url": "https://finnhub.io/api/news?id=aedfbae446e321f3688dd82d97faa05c27cb865785e04975ba20f1a43b8825fb"
    }
  },
  {
    "ts": null,
    "headline": "Solventum: An Impressive Sale Of Purification And Filtration",
    "summary": "Solventum's $4.1B divestment to Thermo Fisher enhances financial stability, boosts EPS, and strengthens its long-term growth potential. Learn more on SOLV stock here.",
    "url": "https://finnhub.io/api/news?id=ed69f71212f0cd43257869aef4dbdcd5d3e3b72c50ec80083d5d6638fd6b323b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740568238,
      "headline": "Solventum: An Impressive Sale Of Purification And Filtration",
      "id": 132878822,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1387451522/image_1387451522.jpg?io=getty-c-w1536",
      "related": "TMO",
      "source": "SeekingAlpha",
      "summary": "Solventum's $4.1B divestment to Thermo Fisher enhances financial stability, boosts EPS, and strengthens its long-term growth potential. Learn more on SOLV stock here.",
      "url": "https://finnhub.io/api/news?id=ed69f71212f0cd43257869aef4dbdcd5d3e3b72c50ec80083d5d6638fd6b323b"
    }
  }
]